Literature DB >> 1743209

Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease).

C Aktolun1, H Bayhan, B Celasun, M K Kir.   

Abstract

The case of a patient with giant lymph node hyperplasia of the mediastinum who unexpectedly showed focal uptake of technetium 99m hexakis-2-methoxyisobutylisonitrile (99mTc-MIBI) is presented in this article. The patient was included in our research programme of tumor imaging with 99mTc-MIBI because the appearance of the mass on the chest radiogram and CT scan resembled a mediastinal tumour. Final diagnosis of giant lymph node hyperplasia was achieved through histopathological examination of the surgically removed lymph node.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1743209     DOI: 10.1007/bf00175067

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  20 in total

1.  Angiofollicular mediastinal lymph-node hyperplasia resembling thymoma.

Authors:  E G HARRISON; P E BERNATZ
Journal:  Arch Pathol       Date:  1963-03

2.  Lymphnodal hamartoma versus thymic choristoma of pulmonary hilum.

Authors:  M R ABELL
Journal:  AMA Arch Pathol       Date:  1957-11

3.  99Tcm sestamibi--a new agent for parathyroid imaging.

Authors:  A J Coakley; A G Kettle; C P Wells; M J O'Doherty; R E Collins
Journal:  Nucl Med Commun       Date:  1989-11       Impact factor: 1.690

4.  The localization of myocardial ischaemia with technetium-99m methoxy isobutyl isonitrile and single photon emission computed tomography.

Authors:  D J West; Y C Najm; R Mistry; S E Clarke; I Fogelman; M N Maisey
Journal:  Br J Radiol       Date:  1989-04       Impact factor: 3.039

5.  Angiofollicular lymph node hyperplasia (Castleman).

Authors:  D Anagnostou; C V Harrison
Journal:  J Clin Pathol       Date:  1972-04       Impact factor: 3.411

6.  Multicentric Castleman's disease in association with a solitary plasmacytoma: a case report.

Authors:  S J Gould; T Diss; P G Isaacson
Journal:  Histopathology       Date:  1990-08       Impact factor: 5.087

7.  Technetium-99m-MIBI and thallium-201 uptake in pulmonary actinomycosis.

Authors:  C Aktolun; D Demirel; M Kir; H Bayhan; H A Maden
Journal:  J Nucl Med       Date:  1991-07       Impact factor: 10.057

8.  Giant lymph node hyperplasia (Castleman's disease) of hyaline vascular type. Clinical heterogeneity with immunohistologic uniformity.

Authors:  J M Martin; B Bell; B A Ruether
Journal:  Am J Clin Pathol       Date:  1985-10       Impact factor: 2.493

9.  Giant lymph node hyperplasia associated with thrombotic thrombocytopenic purpura.

Authors:  W D Couch
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493

10.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

View more
  4 in total

1.  Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas.

Authors:  P Ziegels; M Nocaudie; D Huglo; M Deveaux; L Detourmignies; E Wattel; X Marchandise
Journal:  Eur J Nucl Med       Date:  1995-02

Review 2.  Tracer imaging in lung cancer.

Authors:  H M Abdel-Dayem; A Scott; H Macapinlac; S Larson
Journal:  Eur J Nucl Med       Date:  1994-01

Review 3.  Technetium-99m methoxyisobutylisonitrile localizes an ectopic ACTH-producing tumour: case report and review of the literature.

Authors:  H Jacobsson; G Wallin; S Werner; S A Larsson
Journal:  Eur J Nucl Med       Date:  1994-06

Review 4.  Parathyroid Imaging: Past, Present, and Future.

Authors:  Michael A Morris; Babak Saboury; Mark Ahlman; Ashkan A Malayeri; Elizabeth C Jones; Clara C Chen; Corina Millo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-25       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.